In parallel, the Psychiatric Genome-Wide Association Study (GWAS) Consortium (PGC) identified CSMD1 as one of only seven verified loci in a large schizophrenia GWAS-based meta-analysis involving about 18.000 patients and 34.000 controls [7]. This evidence concerns the gene CSMD1 and schizophrenia.